Imalab

What Imalab does

Imalab S.A. is a Chilean private diagnostic services provider founded in 2013, operating as the first private clinical laboratory, imaging, blood bank, pathological anatomy, and nuclear medicine center embedded within an institutional hospital setting — specifically Hospital FACH (Fuerza Aérea de Chile) in the Las Condes district of Santiago. Its service portfolio covers five integrated diagnostic lines: clinical laboratory (hematology, chemistry, hormones, coagulation, immunology, bacteriology), medical imaging (radiology, teleradiology, MRI, ultrasound, mammography, and CT with a latest-generation 128-channel scanner), blood bank, anatomical pathology, and nuclear medicine. All imaging flows through a unified RIS-PACS digital platform that enables real-time visualization and rapid retrieval, and patients access their results through a dedicated online portal.

The underlying technology stack is anchored by the RIS-PACS integration and the 128-channel CT scanner, which enables coronary AngioTAC and high-resolution 3D imaging. The center has also introduced the ALZ-TAU biomarker kit for pre-clinical Alzheimer's detection, signaling an intent to move beyond conventional diagnostics into specialty biomarker testing. Operational coverage includes 24/7 laboratory service availability for Hospital FACH emergencies and inpatients, with defined outpatient windows for sample collection, imaging, and blood bank services across weekdays and Saturdays.

Imalab's commercial model combines direct-to-consumer appointment scheduling (phone, WhatsApp, website) with broad payer coverage through ISAPRE partnerships (Colmena, Nueva Masvida, CruzBlanca, where covered exams are $0 to insured patients) and FONASA public healthcare. A channel partnership with Examedi extends reach to home-bound patients via in-home sample collection and medical orders. The company operates as a single-location entity within Hospital FACH, with no disclosed funding rounds, M&A activity, or second-site expansion in the available data.

Name

Imalab

Legal name

Imalab S.A.

Website

https://imalab.cl

Company type

Private

Founded year

2013

Operating status

Operating

Short description

Imalab S.A. is a Chilean private diagnostic center founded in 2013, embedded within Hospital FACH in Las Condes, Santiago, providing integrated clinical laboratory, imaging, blood bank, pathology, and nuclear medicine services to ISAPRE-insured, FONASA-covered, and walk-in patients.

Ownership category

akta.pro rank

Product category

Diagnostic Imaging and Laboratory Services

NAICS

Medical and Diagnostic Laboratories (62151), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)

Keywords

• Clinical diagnostic services
• Medical imaging services
• Clinical laboratory testing
• Nuclear medicine diagnostics
• Blood bank services

Headquarters

HQ city

Las Condes

HQ country

Chile

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Infrastructure

Revenue model

1. Clinical Diagnostic Services: Laboratory and imaging diagnostic services provided to inpatients, outpatients, and emergency patients at Hospital FACH. Revenue generated through service fees covered by health insurance (ISAPRE), public healthcare (FONASA), and direct patient payments.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Imalab is a private clinical diagnostic center operating within Hospital FACH in Santiago, Chile. It provides clinical laboratory testing, medical imaging (radiology, CT, MRI, ultrasound, mammography), nuclear medicine, blood bank services, and anatomical pathology. The center integrates these services through a digital RIS-PACS platform and a patient portal for online result retrieval, serving inpatients, emergency patients, and walk-in outpatients.

Product overview

Imalab is a clinical diagnostic services provider operating as a unified multi-specialty platform within Hospital FACH in Santiago, Chile. The portfolio consists of five core diagnostic services: Clinical Laboratory (offering hematology, chemistry, hormones, coagulation, immunology, bacteriology), Medical Imaging (radiology, teleradiology, MRI, CT with 128-channel scanner, ultrasound, mammography), Blood Bank, Anatomical Pathology, and Nuclear Medicine. These services share a unified RIS-PACS digital imaging platform and a Patient Portal for online result retrieval, enabling integrated diagnostic workflows under one institutional roof. The company was founded in 2013 as Chile's first private diagnostic center embedded within a public military hospital.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Laboratory Services (Laboratorio Clínico) Clinical laboratory providing diagnostic testing including hematology, chemistry, hormones, coagulation, immunology, and bacteriology, operating 24 hours daily for inpatients and outpatients. For individual patients, including those covered by ISAPRE (Colmena, Nueva Masvida, CruzBlanca) and FONASA.
• Medical Imaging (Imagenología) Comprehensive medical imaging services including radiology, teleradiology, magnetic resonance imaging (MRI), ultrasound, mammography, and computed tomography with 128-channel scanner, for individual patients requiring diagnostic imaging studies.
• Blood Bank (Banco de Sangre) Blood donation services and blood bank operations supporting hospital transfusion needs, with operating hours for donations and processing. For blood donors and patients requiring transfusion support.
• Anatomical Pathology (Anatomía Patológica) Anatomical pathology services for tissue diagnosis and analysis, supporting clinical decision-making for individual patients.
• Nuclear Medicine (Medicina Nuclear) Nuclear medicine diagnostic imaging services for individual patients requiring specialized functional and metabolic imaging studies.
• ALZ-TAU Biomarker Test A novel biomarker-based test kit enabling detection of Alzheimer's disease before the disease develops. For individual patients seeking early Alzheimer's disease screening.

Quantifiable outcome

• 24/7 laboratory service availability for emergencies

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Colmena (ISAPRE)coreOthersHealth insurance partnership allowing Colmena beneficiaries to access diagnostic services at $0 cost according to individual patient insurance agreements.
• Nueva Masvida (ISAPRE)coreOthersHealth insurance partnership allowing Nueva Masvida beneficiaries to access diagnostic services at $0 cost according to individual patient insurance agreements.
• CruzBlanca (ISAPRE)coreOthersHealth insurance partnership allowing CruzBlanca beneficiaries to access diagnostic services at $0 cost according to individual patient insurance agreements.
• FONASAcoreOthersPublic healthcare system partnership allowing FONASA beneficiaries to access Imalab diagnostic services covered under public health insurance.
• ExamediminorChannel Partner/ Reseller/ DistributorPartner for home examination services, providing medical orders and home sample collection for patients unable to visit the laboratory in person.
• Hospital FACH (Fuerza Aérea de Chile)coreStrategic or Co-development PartnerHost institution providing the facility for Imalab's diagnostic center. Imalab is the first private diagnostic center operating within Hospital FACH, delivering laboratory, blood bank, pathological anatomy, imaging, and nuclear medicine services within the hospital.

Scale indicators2 records

Recent moves6 records

Expansion highlights3 records

Others

• FONASA: Chile's public health insurance administrator and an Imalab payor partner — not a direct competitor but a structural counterpart defining the public-payor revenue channel Imalab accesses.
• Examedi: Chilean home-based diagnostic services platform and Imalab's existing channel partner for home examinations — adjacent ecosystem participant enabling patient access rather than a direct competitor.

Broad incumbents

• Synlab: European-headquartered clinical laboratory and diagnostic services operator with extensive multi-site networks — a broader incumbent comparable to Imalab's multi-specialty lab operations.
• Eurofins: Global laboratory testing services group spanning clinical diagnostics, pharma services, and specialty testing — a broad incumbent whose diagnostic offering overlaps with Imalab's clinical laboratory and pathology services.
• Quest Diagnostics: Global independent diagnostic testing and laboratory services incumbent; broadly comparable to Imalab's clinical laboratory business model and payor-driven revenue structure.

Direct peers

• RedSalud: Chile's largest private healthcare network, operating multiple diagnostic centers across imaging, laboratory, and specialty services — directly competing with Imalab for ambulatory diagnostic volumes in Santiago and other regions.
• Hospital Clínico Universidad de Chile: Academic hospital operating in-house diagnostic imaging, laboratory, and pathology services — comparable to Imalab's hospital-embedded diagnostic delivery model.
• UC Christus: Chilean private health network affiliated with Pontificia Universidad Católica, providing diagnostic imaging and laboratory services — a direct competitor in the Santiago ambulatory diagnostic market.
• IntegraMédica: Multi-site Chilean outpatient diagnostic chain offering imaging and laboratory services — competes directly with Imalab for ambulatory patients and insurance-covered exams in Santiago.
• Clínica Alemana: Major Santiago private hospital with embedded diagnostic imaging and laboratory services — closely comparable to Imalab's hospital-embedded multi-specialty diagnostic model.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/imalab.cl
• LinkedInlinkedin.com/company/imalab-s-a

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imalab